Interdict Bio
Interdict | Home
San Francisco, United States · $26.5M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- interdictbio.com
- Total Funding
- $26.5M
- Last Round
- $17.5M Series ASep 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Developer of small molecule Interdictor therapeutics that inhibit ribosomal protein synthesis to address historically undruggable targets.
Summary
Interdict Bio is a Biotech company based in San Francisco, United States. It has raised $26.5M in total across 2 rounds, most recently a $17.5M Series A round in Sep 2025. Investors include Altitude Life Science Ventures, Mission Bay Capital and Venrock.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/interdict-bio"><img src="https://indexed.vc/api/badge/company/interdict-bio" alt="Interdict Bio on Indexed.vc" width="260" height="76" /></a>